Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Stroke

Free Subscription Articles published in Lancet Retrieve available abstracts of 118 articles: HTML format

Single Articles

December 2025
1. 
   Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021.
   Lancet. 2025;404:2543-2583.
   PubMed     Abstract available
   
   
   
2. KEDHI E, Hermanides RS, Dambrink JE, Singh SK, et al
   TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and c
   Lancet. 2025;404:2593-2602.
   PubMed     Abstract available
   
   
   October 2025
3. FEIGIN VL, Martins SO, Hankey GJ
   Rethinking atherosclerotic disease prevention.
   Lancet. 2025;406:1947.
   PubMed    
   
   
   
4. DEANFIELD J, Lincoff AM, Kahn SE, Emerson SS, et al
   Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial.
   Lancet. 2025 Oct 22:S0140-6736(25)01375-3. doi: 10.1016/S0140-6736(25)01375.
   PubMed     Abstract available
   
   
   
5. 
   Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
   Lancet. 2025 Oct 12:S0140-6736(25)01917-8. doi: 10.1016/S0140-6736(25)01917.
   PubMed     Abstract available
   
   
   
6. 
   Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023.
   Lancet. 2025 Oct 12:S0140-6736(25)01330-3. doi: 10.1016/S0140-6736(25)01330.
   PubMed     Abstract available
   
   
   
7. 
   Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Stud
   Lancet. 2025 Oct 12:S0140-6736(25)01637-X. doi: 10.1016/S0140-6736(25)01637.
   PubMed     Abstract available
   
   
   September 2025
8. FRISONI GB, Aho E, Brayne C, Ciccarelli O, et al
   Alzheimer's disease outlook: controversies and future directions.
   Lancet. 2025;406:1424-1442.
   PubMed     Abstract available
   
   
   
9. FOX NC, Belder C, Ballard C, Kales HC, et al
   Treatment for Alzheimer's disease.
   Lancet. 2025;406:1408-1423.
   PubMed     Abstract available
   
   
   
10. FRISONI GB, Hansson O, Nichols E, Garibotto V, et al
    New landscape of the diagnosis of Alzheimer's disease.
    Lancet. 2025;406:1389-1407.
    PubMed     Abstract available
    
    
    
11. 
    The global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023.
    Lancet. 2025 Sep 24:S0140-6736(25)01635-6. doi: 10.1016/S0140-6736(25)01635.
    PubMed     Abstract available
    
    
    
12. OCHOA-URREA M, Luo X, Vilella L, Lacuey N, et al
    Risk markers for sudden unexpected death in epilepsy: an observational, prospective, multicentre cohort study.
    Lancet. 2025 Sep 17:S0140-6736(25)01636-8. doi: 10.1016/S0140-6736(25)01636.
    PubMed     Abstract available
    
    
    August 2025
13. ROSSELLO X, Prescott EIB, Kristensen AMD, Latini R, et al
    beta blockers after myocardial infarction with mildly reduced ejection fraction: an individual patient data meta-analysis of randomised controlled trials.
    Lancet. 2025 Aug 29:S0140-6736(25)01592-2. doi: 10.1016/S0140-6736(25)01592.
    PubMed     Abstract available
    
    
    
14. GUO X, Sun G, Xu Y, Zhou S, et al
    Benefit-harm trade-offs of intensive blood pressure control versus standard blood pressure control on cardiovascular and renal outcomes: an individual participant data analysis of randomised controlled trials.
    Lancet. 2025 Aug 28:S0140-6736(25)01391-1. doi: 10.1016/S0140-6736(25)01391.
    PubMed     Abstract available
    
    
    
15. VALGIMIGLI M, Choi KH, Giacoppo D, Gragnano F, et al
    Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysis.
    Lancet. 2025 Aug 28:S0140-6736(25)01562-4. doi: 10.1016/S0140-6736(25)01562.
    PubMed     Abstract available
    
    
    
16. KIM MC, Ahn JH, Hyun DY, Lim Y, et al
    Immediate versus staged complete revascularisation during index admission in patients with ST-segment elevation myocardial infarction and multivessel disease (OPTION-STEMI): a multicentre, non-inferiority, open-label, randomised trial.
    Lancet. 2025 Aug 28:S0140-6736(25)01529-6. doi: 10.1016/S0140-6736(25)01529.
    PubMed     Abstract available
    
    
    
17. ANDERSON CS, Hua C, Wang Z, Wang C, et al
    Influenza vaccination to improve outcomes for patients with acute heart failure (PANDA II): a multiregional, seasonal, hospital-based, cluster-randomised, controlled trial in China.
    Lancet. 2025 Aug 28:S0140-6736(25)01485-0. doi: 10.1016/S0140-6736(25)01485.
    PubMed     Abstract available
    
    
    
18. ROSSIGNOL P, Zannad F, Massy Z, Azizi M, et al
    Spironolactone in patients on chronic haemodialysis at high risk of adverse cardiovascular outcomes (ALCHEMIST): a multicentre, double-blind, randomised, placebo-controlled trial and updated meta-analysis.
    Lancet. 2025;406:705-718.
    PubMed     Abstract available
    
    
    
19. ROSENTHAL LS, Farag M, Aziz NA, Bang J, et al
    Vesicular monoamine transport inhibitors: current uses and future directions.
    Lancet. 2025;406:650-664.
    PubMed     Abstract available
    
    
    
20. CHENG SP, Chen PH, Jhou HJ
    Timing of cardiac surgery and anticoagulants after acute ischaemic stroke.
    Lancet. 2025;406:601.
    PubMed    
    
    
    
21. WERRING DJ, Dehbi HM, Best JG, Nash PS, et al
    Timing of cardiac surgery and anticoagulants after acute ischaemic stroke - Authors' reply.
    Lancet. 2025;406:601-602.
    PubMed    
    
    
    
22. POCAR M, Barbero C, Cerrato P, De Rosa FG, et al
    Timing of cardiac surgery and anticoagulants after acute ischaemic stroke.
    Lancet. 2025;406:600-601.
    PubMed    
    
    
    June 2025
23. 
    Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023.
    Lancet. 2025 Jun 24:S0140-6736(25)01037-2. doi: 10.1016/S0140-6736(25)01037.
    PubMed     Abstract available
    
    
    
24. ZIAI WC, Tsivgoulis G
    Timing of anticoagulation after ischaemic stroke and atrial fibrillation: better swift than sorry.
    Lancet. 2025 Jun 23:S0140-6736(25)00676-2. doi: 10.1016/S0140-6736(25)00676.
    PubMed    
    
    
    
25. DEHBI HM, Fischer U, Asberg S, Milling TJ, et al
    Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST).
    Lancet. 2025 Jun 23:S0140-6736(25)00439-8. doi: 10.1016/S0140-6736(25)00439.
    PubMed     Abstract available
    
    
    
26. DENT E, Clegg A, Roller-Wirnsberger R, Vetrano DL, et al
    Reorienting frailty in clinical practice, public health, and policy: the Lancet Commission on Frailty.
    Lancet. 2025 Jun 5:S0140-6736(25)01101-8. doi: 10.1016/S0140-6736(25)01101.
    PubMed    
    
    
    May 2025
27. ASHCRAFT S
    Safety of low-intensity monitoring after thrombolysis in acute ischaemic stroke.
    Lancet. 2025;405:1884-1885.
    PubMed    
    
    
    
28. SHNEIDER NA, Harms MB, Korobeynikov VA, Rifai OM, et al
    Antisense oligonucleotide jacifusen for FUS-ALS: an investigator-initiated, multicentre, open-label case series.
    Lancet. 2025 May 22:S0140-6736(25)00513-6. doi: 10.1016/S0140-6736(25)00513.
    PubMed     Abstract available
    
    
    
29. ANDERSON CS, Summers D, Ouyang M, Sui Y, et al
    Safety and efficacy of low-intensity versus standard monitoring following intravenous thrombolytic treatment in patients with acute ischaemic stroke (OPTIMISTmain): an international, pragmatic, stepped-wedge, cluster-randomised, controlled non-inferio
    Lancet. 2025 May 20:S0140-6736(25)00549-5. doi: 10.1016/S0140-6736(25)00549.
    PubMed     Abstract available
    
    
    
30. MAKKAR RR, Ramana RK, Gnall E, Ramlawi B, et al
    ACURATE neo2 valve versus commercially available transcatheter heart valves in patients with severe aortic stenosis (ACURATE IDE): a multicentre, randomised, controlled, non-inferiority trial.
    Lancet. 2025 May 20:S0140-6736(25)00319-8. doi: 10.1016/S0140-6736(25)00319.
    PubMed     Abstract available
    
    
    
31. SONG L, Li Q, Anderson CS
    Traditional Chinese medicine for acute intracerebral haemorrhage - Authors' reply.
    Lancet. 2025;405:1741-1742.
    PubMed    
    
    
    March 2025
32. CHOI KH, Park YH, Lee JY, Jeong JO, et al
    Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial.
    Lancet. 2025 Mar 28:S0140-6736(25)00449-0. doi: 10.1016/S0140-6736(25)00449.
    PubMed     Abstract available
    
    
    
33. FEARON WF, Zimmermann FM, Ding VY, Takahashi K, et al
    Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trial.
    Lancet. 2025 Mar 28:S0140-6736(25)00505-7. doi: 10.1016/S0140-6736(25)00505.
    PubMed     Abstract available
    
    
    
34. 
    Global, regional, and national burden of household air pollution, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet. 2025 Mar 18:S0140-6736(24)02840-X. doi: 10.1016/S0140-6736(24)02840.
    PubMed     Abstract available
    
    
    February 2025
35. 
    Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021.
    Lancet. 2025 Feb 28:S0140-6736(25)00355-1. doi: 10.1016/S0140-6736(25)00355.
    PubMed     Abstract available
    
    
    
36. 
    Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021.
    Lancet. 2025 Feb 28:S0140-6736(25)00397-6. doi: 10.1016/S0140-6736(25)00397.
    PubMed     Abstract available
    
    
    
37. SALMAN RA, Shoamanesh A
    Towards definitive evidence about anticoagulation for atrial fibrillation after intracranial haemorrhage.
    Lancet. 2025 Feb 26:S0140-6736(25)00366-6. doi: 10.1016/S0140-6736(25)00366.
    PubMed    
    
    
    
38. VELTKAMP R, Korompoki E, Harvey KH, Harvey ER, et al
    Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial.
    Lancet. 2025 Feb 26:S0140-6736(25)00333-2. doi: 10.1016/S0140-6736(25)00333.
    PubMed     Abstract available
    
    
    
39. CHRISTENSON J, Hill MD, Swartz RH, Adams C, et al
    Efficacy and safety of intravenous nerinetide initiated by paramedics in the field for acute cerebral ischaemia within 3 h of symptom onset (FRONTIER): a phase 2, multicentre, randomised, double-blind, placebo-controlled study.
    Lancet. 2025;405:571-582.
    PubMed     Abstract available
    
    
    
40. HILL MD, Goyal M, Demchuk AM, Menon BK, et al
    Efficacy and safety of nerinetide in acute ischaemic stroke in patients undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT): a multicentre, double-blind, randomised controlled trial.
    Lancet. 2025;405:560-570.
    PubMed     Abstract available
    
    
    
41. KOOHI N, Simonyan S, Joffily L, Simister R, et al
    Testing hearing in suspected stroke: a diagnostic opportunity.
    Lancet. 2025;405:540-541.
    PubMed    
    
    
    
42. LIBERMAN AL, Levine SR
    Ischaemic brain neuroprotection: a true therapeutic frontier?
    Lancet. 2025;405:519-521.
    PubMed    
    
    
    
43. LI W, Lan J, Wei M, Liu L, et al
    Normobaric hyperoxia combined with endovascular treatment for acute ischaemic stroke in China (OPENS-2 trial): a multicentre, randomised, single-blind, sham-controlled trial.
    Lancet. 2025;405:486-497.
    PubMed     Abstract available
    
    
    
44. DIPPEL DWJ, Janssen PM
    Effect of normobaric hyperoxia in ischaemic stroke.
    Lancet. 2025;405:442-443.
    PubMed    
    
    
    January 2025
45. WILLIAMS MC, Wereski R, Tuck C, Adamson PD, et al
    Coronary CT angiography-guided management of patients with stable chest pain: 10-year outcomes from the SCOT-HEART randomised controlled trial in Scotland.
    Lancet. 2025;405:329-337.
    PubMed     Abstract available
    
    
    December 2024
46. NOGUEIRA RG, Jovin TG, Liu X, Hu W, et al
    Endovascular therapy for acute vertebrobasilar occlusion (VERITAS): a systematic review and individual patient data meta-analysis.
    Lancet. 2024 Dec 11:S0140-6736(24)01820-8. doi: 10.1016/S0140-6736(24)01820.
    PubMed     Abstract available
    
    
    
47. HO JK, Hankey GJ
    Endovascular therapy for ischaemic stroke due to vertebrobasilar artery occlusion.
    Lancet. 2024 Dec 11:S0140-6736(24)02137-8. doi: 10.1016/S0140-6736(24)02137.
    PubMed    
    
    
    
48. 
    Burden of disease scenarios by state in the USA, 2022-50: a forecasting analysis for the Global Burden of Disease Study 2021.
    Lancet. 2024;404:2341-2370.
    PubMed     Abstract available
    
    
    
49. 
    The burden of diseases, injuries, and risk factors by state in the USA, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet. 2024;404:2314-2340.
    PubMed     Abstract available
    
    
    November 2024
50. DHILLON PS, Nguyen TN
    Temporary blood flow arrest during endovascular thrombectomy for acute ischaemic stroke.
    Lancet. 2024 Nov 20:S0140-6736(24)02461-9. doi: 10.1016/S0140-6736(24)02461.
    PubMed    
    
    
    
51. LIU J, Zhou Y, Zhang L, Li Z, et al
    Balloon guide catheters for endovascular thrombectomy in patients with acute ischaemic stroke due to large-vessel occlusion in China (PROTECT-MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial.
    Lancet. 2024 Nov 20:S0140-6736(24)02315-8. doi: 10.1016/S0140-6736(24)02315.
    PubMed     Abstract available
    
    
    
52. 
    National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990-2021, and forecasts up to 2050.
    Lancet. 2024 Nov 12:S0140-6736(24)01548-4. doi: 10.1016/S0140-6736(24)01548.
    PubMed     Abstract available
    
    
    
53. WU S
    Integrative medicine for the treatment of stroke.
    Lancet. 2024 Nov 12:S0140-6736(24)02257-8. doi: 10.1016/S0140-6736(24)02257.
    PubMed    
    
    
    
54. GUO J, Chen X, Wu M, Wang D, et al
    Traditional Chinese medicine FYTF-919 (Zhongfeng Xingnao oral prescription) for the treatment of acute intracerebral haemorrhage: a multicentre, randomised, placebo-controlled, double-blind, clinical trial.
    Lancet. 2024 Nov 12:S0140-6736(24)02261-X. doi: 10.1016/S0140-6736(24)02261.
    PubMed     Abstract available
    
    
    
55. 
    Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990-2021: findings from the Global Burden of Disease Study 2021.
    Lancet. 2024 Nov 4:S0140-6736(24)01925-1. doi: 10.1016/S0140-6736(24)01925.
    PubMed     Abstract available
    
    
    
56. THOMALLA G, Bonekamp S, Fiehler J, Bendszus M, et al
    Endovascular thrombectomy for acute ischaemic stroke: the TENSION trial - Authors' reply.
    Lancet. 2024;404:1729-1730.
    PubMed    
    
    
    
57. JHOU HJ, Yang LY, Chen PH
    Endovascular thrombectomy for acute ischaemic stroke: the TENSION trial.
    Lancet. 2024;404:1728.
    PubMed    
    
    
    
58. WANG Z, Huang K, Huang ZX
    Endovascular thrombectomy for acute ischaemic stroke: the TENSION trial.
    Lancet. 2024;404:1728-1729.
    PubMed    
    
    
    
59. BROOCKS G, Kemmling A
    Endovascular thrombectomy for acute ischaemic stroke: the TENSION trial.
    Lancet. 2024;404:1727-1728.
    PubMed    
    
    
    October 2024
60. WERRING DJ, Dehbi HM, Ahmed N, Arram L, et al
    Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial.
    Lancet. 2024 Oct 23:S0140-6736(24)02197-4. doi: 10.1016/S0140-6736(24)02197.
    PubMed     Abstract available
    
    
    
61. SANDSET EC, de Sousa DA
    Optimal anticoagulation timing after ischaemic stroke in patients with atrial fibrillation.
    Lancet. 2024 Oct 23:S0140-6736(24)02259-1. doi: 10.1016/S0140-6736(24)02259.
    PubMed    
    
    
    September 2024
62. NGUYEN TN, Abdalkader M, Fischer U, Qiu Z, et al
    Endovascular management of acute stroke.
    Lancet. 2024;404:1265-1278.
    PubMed     Abstract available
    
    
    
63. NARAGHI K, Marzo-Ortega H
    Progressive cervical osteophytosis and dysphagia associated with isotretinoin treatment for rosacea.
    Lancet. 2024;404:e4.
    PubMed    
    
    
    
64. 
    Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050.
    Lancet. 2024 Sep 13:S0140-6736(24)01867-1. doi: 10.1016/S0140-6736(24)01867.
    PubMed     Abstract available
    
    
    August 2024
65. HONG SJ, Lee SJ, Lee SH, Lee JY, et al
    Optical coherence tomography-guided versus angiography-guided percutaneous coronary intervention for patients with complex lesions (OCCUPI): an investigator-initiated, multicentre, randomised, open-label, superiority trial in South Korea.
    Lancet. 2024 Aug 30:S0140-6736(24)01454-5. doi: 10.1016/S0140-6736(24)01454.
    PubMed     Abstract available
    
    
    
66. VALGIMIGLI M, Hong SJ, Gragnano F, Chalkou K, et al
    De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials.
    Lancet. 2024 Aug 30:S0140-6736(24)01616-7. doi: 10.1016/S0140-6736(24)01616.
    PubMed     Abstract available
    
    
    
67. JHUND PS, Talebi A, Henderson AD, Claggett BL, et al
    Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis.
    Lancet. 2024 Aug 30:S0140-6736(24)01733-1. doi: 10.1016/S0140-6736(24)01733.
    PubMed     Abstract available
    
    
    
68. KOSIBOROD MN, Deanfield J, Pratley R, Borlaug BA, et al
    Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials.
    Lancet. 2024 Aug 29:S0140-6736(24)01643-X. doi: 10.1016/S0140-6736(24)01643.
    PubMed     Abstract available
    
    
    
69. DEANFIELD J, Verma S, Scirica BM, Kahn SE, et al
    Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial.
    Lancet. 2024;404:773-786.
    PubMed     Abstract available
    
    
    
70. JAVED S, Zaidi DA, Yaqoob E
    Addressing the deficiencies in stroke care in Pakistan.
    Lancet. 2024;404:651-652.
    PubMed    
    
    
    
71. COUTTS SB, Sprigg N
    Human rights considerations are key when choosing a conference location.
    Lancet. 2024 Aug 16:S0140-6736(24)01503-4. doi: 10.1016/S0140-6736(24)01503.
    PubMed    
    
    
    
72. MANLEY GT, Maas AI
    The Glasgow Coma Scale at 50: looking back and forward.
    Lancet. 2024 Aug 14:S0140-6736(24)01596-4. doi: 10.1016/S0140-6736(24)01596.
    PubMed    
    
    
    July 2024
73. JOUNDI RA, Hu B, Rangarajan S, Leong DP, et al
    Activity limitations, use of assistive devices, and mortality and clinical events in 25 high-income, middle-income, and low-income countries: an analysis of the PURE study.
    Lancet. 2024 Jul 25:S0140-6736(24)01050-X. doi: 10.1016/S0140-6736(24)01050.
    PubMed     Abstract available
    
    
    June 2024
74. LIU J, Li Y, Ge J, Yan X, et al
    Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial.
    Lancet. 2024 Jun 27:S0140-6736(24)01028-6. doi: 10.1016/S0140-6736(24)01028.
    PubMed     Abstract available
    
    
    
75. KELLY P, Lemmens R, Weimar C, Walsh C, et al
    Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial.
    Lancet. 2024 Jun 7:S0140-6736(24)00968-1. doi: 10.1016/S0140-6736(24)00968.
    PubMed     Abstract available
    
    
    
76. KATSANOS AH, Shoamanesh A
    Colchicine for the prevention of vascular events after non-cardioembolic stroke.
    Lancet. 2024 Jun 7:S0140-6736(24)01096-1. doi: 10.1016/S0140-6736(24)01096.
    PubMed    
    
    
    May 2024
77. BAUMBACH A, van Royen N, Amat-Santos IJ, Hudec M, et al
    LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial.
    Lancet. 2024 May 22:S0140-6736(24)00821-3. doi: 10.1016/S0140-6736(24)00821.
    PubMed     Abstract available
    
    
    
78. 
    Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.
    Lancet. 2024;403:2204-2256.
    PubMed     Abstract available
    
    
    
79. 
    Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet. 2024;403:2162-2203.
    PubMed     Abstract available
    
    
    
80. ADLER AI, Coleman RL, Leal J, Whiteley WN, et al
    Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91).
    Lancet. 2024 May 17:S0140-6736(24)00537-3. doi: 10.1016/S0140-6736(24)00537.
    PubMed     Abstract available
    
    
    
81. COUTTS SB, Ankolekar S, Appireddy R, Arenillas JF, et al
    Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial.
    Lancet. 2024 May 16:S0140-6736(24)00921-8. doi: 10.1016/S0140-6736(24)00921.
    PubMed     Abstract available
    
    
    
82. SACCO S, Turc G
    Advances and challenges in the acute treatment of minor ischaemic stroke.
    Lancet. 2024 May 16:S0140-6736(24)00981-4. doi: 10.1016/S0140-6736(24)00981.
    PubMed    
    
    
    
83. HILKENS NA, Casolla B, Leung TW, de Leeuw FE, et al
    Stroke.
    Lancet. 2024 May 14:S0140-6736(24)00642-1. doi: 10.1016/S0140-6736(24)00642.
    PubMed     Abstract available
    
    
    
84. BECK J, Fung C, Strbian D, Butikofer L, et al
    Decompressive craniectomy plus best medical treatment versus best medical treatment alone for spontaneous severe deep supratentorial intracerebral haemorrhage: a randomised controlled clinical trial.
    Lancet. 2024 May 14:S0140-6736(24)00702-5. doi: 10.1016/S0140-6736(24)00702.
    PubMed     Abstract available
    
    
    
85. KLIJN CJ, Dammers R, Sprigg N
    Decompressive craniectomy for deep intracerebral haemorrhage: a SWITCH towards better outcomes?
    Lancet. 2024 May 14:S0140-6736(24)00703-7. doi: 10.1016/S0140-6736(24)00703.
    PubMed    
    
    
    April 2024
86. 
    Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a sys
    Lancet. 2024 Apr 15:S0140-6736(24)00757-8. doi: 10.1016/S0140-6736(24)00757.
    PubMed     Abstract available
    
    
    
87. GE Z, Kan J, Gao X, Raza A, et al
    Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial.
    Lancet. 2024 Apr 5:S0140-6736(24)00473-2. doi: 10.1016/S0140-6736(24)00473.
    PubMed     Abstract available
    
    
    
88. PARK SJ, Ahn JM, Kang DY, Yun SC, et al
    Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial.
    Lancet. 2024 Apr 4:S0140-6736(24)00413-6. doi: 10.1016/S0140-6736(24)00413.
    PubMed     Abstract available
    
    
    
89. 
    Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet. 2024 Apr 3:S0140-6736(24)00367-2. doi: 10.1016/S0140-6736(24)00367.
    PubMed     Abstract available
    
    
    March 2024
90. VAHL TP, Thourani VH, Makkar RR, Hamid N, et al
    Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm study.
    Lancet. 2024 Mar 26:S0140-6736(23)02806-4. doi: 10.1016/S0140-6736(23)02806.
    PubMed     Abstract available
    
    
    
91. MELLO A, Stehr D, Bujarski K, Duchaine B, et al
    Visualising facial distortions in prosopometamorphopsia.
    Lancet. 2024;403:1176.
    PubMed    
    
    
    
92. 
    Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
    Lancet. 2024 Mar 19:S0140-6736(24)00550-6. doi: 10.1016/S0140-6736(24)00550.
    PubMed     Abstract available
    
    
    
93. CHEN WG, Edwards E, Iyengar S, Finkelstein R, et al
    Music and medicine: quickening the tempo of progress.
    Lancet. 2024 Mar 18:S0140-6736(24)00477-X. doi: 10.1016/S0140-6736(24)00477.
    PubMed    
    
    
    
94. 
    Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden
    Lancet. 2024 Mar 8:S0140-6736(24)00476-8. doi: 10.1016/S0140-6736(24)00476.
    PubMed     Abstract available
    
    
    February 2024
95. CONSOLI A, Gory B
    Long-term results of mechanical thrombectomy for large ischaemic stroke.
    Lancet. 2024 Feb 8:S0140-6736(24)00158-2. doi: 10.1016/S0140-6736(24)00158.
    PubMed    
    
    
    
96. SARRAJ A, Abraham MG, Hassan AE, Blackburn S, et al
    Endovascular thrombectomy plus medical care versus medical care alone for large ischaemic stroke: 1-year outcomes of the SELECT2 trial.
    Lancet. 2024 Feb 8:S0140-6736(24)00050-3. doi: 10.1016/S0140-6736(24)00050.
    PubMed     Abstract available
    
    
    January 2024
97. BEN-SHLOMO Y, Darweesh S, Llibre-Guerra J, Marras C, et al
    The epidemiology of Parkinson's disease.
    Lancet. 2024;403:283-292.
    PubMed     Abstract available
    
    
    November 2023
98. FROST R, Avgerinou C, Kalwarowsky S, Mahmood F, et al
    Enabling health and maintaining independence for older people at home (HomeHealth trial): a multicentre randomised controlled trial.
    Lancet. 2023;402 Suppl 1:S42.
    PubMed     Abstract available
    
    
    
99. BARRADO-MARTIN Y, Frost R, Catchpole J, Rookes T, et al
    Goal setting as part of a holistic intervention to promote independence in older people with mild frailty: a process evaluation alongside a randomised controlled trial.
    Lancet. 2023;402 Suppl 1:S1.
    PubMed     Abstract available
    
    
    
100. LIU L, Li X, Marshall IJ, Bhalla A, et al
     Trajectories of depressive symptoms 10 years after stroke and associated risk factors: a prospective cohort study.
     Lancet. 2023;402 Suppl 1:S64.
     PubMed     Abstract available
     
     
     October 2023
101. MESSERLI FH, Bangalore S, Mandrola JM
     beta blockers switched to first-line therapy in hypertension.
     Lancet. 2023 Oct 13:S0140-6736(23)01733-6. doi: 10.1016/S0140-6736(23)01733.
     PubMed     Abstract available
     
     
     
102. DIPPEL DWJ, Roozenbeek B
     Thrombectomy for acute ischaemic stroke without advanced imaging.
     Lancet. 2023 Oct 10:S0140-6736(23)02229-8. doi: 10.1016/S0140-6736(23)02229.
     PubMed    
     
     
     
103. BENDSZUS M, Fiehler J, Subtil F, Bonekamp S, et al
     Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial.
     Lancet. 2023 Oct 10:S0140-6736(23)02032-9. doi: 10.1016/S0140-6736(23)02032.
     PubMed     Abstract available
     
     
     August 2023
104. MAKKAR RR, Kapadia S, Chakravarty T, Cubeddu RJ, et al
     Outcomes of repeat transcatheter aortic valve replacement with balloon-expandable valves: a registry study.
     Lancet. 2023 Aug 31:S0140-6736(23)01636-7. doi: 10.1016/S0140-6736(23)01636.
     PubMed     Abstract available
     
     
     
105. MAJOIE CB, Cavalcante F, Gralla J, Yang P, et al
     Value of intravenous thrombolysis in endovascular treatment for large-vessel anterior circulation stroke: individual participant data meta-analysis of six randomised trials.
     Lancet. 2023 Aug 25:S0140-6736(23)01142-X. doi: 10.1016/S0140-6736(23)01142.
     PubMed     Abstract available
     
     
     
106. HANKEY GJ
     Does thrombolysis add value to thrombectomy for acute ischaemic stroke?
     Lancet. 2023 Aug 25:S0140-6736(23)01202-3. doi: 10.1016/S0140-6736(23)01202.
     PubMed    
     
     
     
107. WILKOFF BL, Filippatos G, Leclercq C, Gold MR, et al
     Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial.
     Lancet. 2023 Aug 24:S0140-6736(23)00912-1. doi: 10.1016/S0140-6736(23)00912.
     PubMed     Abstract available
     
     
     July 2023
108. STRANDELL A, Hellgren M
     Time to stop routine prescription of low-molecular-weight heparin to women with recurrent pregnancy loss and inherited thrombophilia.
     Lancet. 2023;402:6-7.
     PubMed    
     
     
     June 2023
109. HUANG C, Huang L, Wang Y, Li X, et al
     6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
     Lancet. 2023 Jun 12:S0140-6736(23)00810-3. doi: 10.1016/S0140-6736(23)00810.
     PubMed     Abstract available
     
     
     May 2023
110. MA L, Hu X, Song L, Chen X, et al
     The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial.
     Lancet. 2023 May 24:S0140-6736(23)00806-1. doi: 10.1016/S0140-6736(23)00806.
     PubMed     Abstract available
     
     
     April 2023
111. WARDLAW JM
     Even more benefit with endovascular treatment for patients with acute ischaemic stroke: MR CLEAN-LATE.
     Lancet. 2023;401:1317-1319.
     PubMed    
     
     
     
112. HAWKEY C
     Helicobacter pylori eradication and aspirin: a puzzle yet to be solved - Author's reply.
     Lancet. 2023;401:1266.
     PubMed    
     
     
     
113. GATTA L, Zullo A, Vaira D
     Helicobacter pylori eradication and aspirin: a puzzle yet to be solved.
     Lancet. 2023;401:1265-1266.
     PubMed    
     
     
     
114. LI Y, Liang Z, Stone GW, Han Y, et al
     BRIGHT-4 trial: bivalirudin strikes back - Authors' reply.
     Lancet. 2023;401:1158.
     PubMed    
     
     
     
115. PIRIOU PG, Manigold T, Letocart V, Guerin P, et al
     BRIGHT-4 trial: bivalirudin strikes back.
     Lancet. 2023;401:1157-1158.
     PubMed    
     
     
     March 2023
116. OLTHUIS SGH, Pirson FAV, Pinckaers FME, Hinsenveld WH, et al
     Endovascular treatment versus no endovascular treatment after 6-24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase
     Lancet. 2023 Mar 29:S0140-6736(23)00575-5. doi: 10.1016/S0140-6736(23)00575.
     PubMed     Abstract available
     
     
     
117. KLOK FA, Siegerink B
     Ordinal outcomes add value to clinical trials.
     Lancet. 2023;401:995.
     PubMed    
     
     
     
118. HE J, Ouyang N, Guo X, Sun G, et al
     Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial.
     Lancet. 2023 Mar 2:S0140-6736(22)02603-4. doi: 10.1016/S0140-6736(22)02603.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Stroke is free of charge.